ARTURO MARTINEZ: Open Payments
NPI 1235159104 · LAREDO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 22 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $153 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $104 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| Novo Nordisk Inc | 3 | $52 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Corcept Therapeutics | 2 | $47 |
| Lundbeck LLC | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| PFIZER INC. | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: MOUNJARO, GEMTESA, Korlym, REXULTI, Ozempic, Kerendia, SHINGRIX, PAXLOVID.
Industry payments across TX — which companies pay providers there.
